The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
B16 as a Mouse Model for Human Melanoma
Open accessAbstract
This unit details protocols for in vivo models of subcutaneous growth and pulmonary metastases of B16 melanoma. Therapeutic approaches include the use of B16.GM‐CSF and rVVmTRP‐1 to induce autoimmune vitiligo and tumor protection. The induction and use of gp100‐specific therapeutic cytotoxic T lymphocytes (CTL) are discussed. Methods are also included for CTL induction, isolation and testing, CTL maintenance, and adoptive transfer. Support protocols detail the testing of mouse sera for presence of MDA‐specific antibodies by immunoblotting and ELISA, respectively. Additional sections, including growing B16 melanoma, enumerating pulmonary metastases, and use of recombinant viruses for vaccination, are discussed together with safety concerns.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Centers for Disease Control and Prevention
(2007) · Encyclopedia of Measurement and Statistics · doi:10.4135/9781412952644.n74 · Cited by 6,444
Dranoff, G., Jaffee, E., Lazenby, A., Golumbek, P., Levitsky, H., Brose, K., Jackson, V, Hamada, H., Pardoll, D., & Mulligan, R. C. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.8.3539 · Cited by 2,818
Current Protocols in Molecular Biology
Teplitz, R. (1989) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1989.03420090114049 · Cited by 1,803
The Central Role of CD4+ T Cells in the Antitumor Immune Response
Hung, K., Hayashi, R., Lafond-Walker, A., Lowenstein, C., Pardoll, D., & Levitsky, H. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.12.2357 · Cited by 1,345
van Elsas, A., Hurwitz, A. A., & Allison, J. P. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.3.355 · Cited by 1,020 · cited 2×
“GMCSF), particularly when administered together with anti-CTLA-4 antibody (Hung et al., 1998; van Elsas et al., 1999).”
BackgroundKawakami, Y., Eliyahu, S., Sakaguchi, K., Robbins, P. F., Rivoltini, L., Yannelli, J. R., Appella, E., & Rosenberg, S. A. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.1.347 · Cited by 862
Identification of a Peptide Recognized by Five Melanoma-Specific Human Cytotoxic T Cell Lines
Cox, A. L., Skipper, J., Chen, Y., Henderson, R. A., Darrow, T. L., Shabanowitz, J., Engelhard, V. H., Hunt, D. F., & Slingluff, C. L. (1994) · Science · doi:10.1126/science.7513441 · Cited by 824
A New Era for Cancer Immunotherapy Based on the Genes that Encode Cancer Antigens
Rosenberg, S. A. (1999) · Immunity · doi:10.1016/s1074-7613(00)80028-x · Cited by 566
Kawakami, Y., Eliyahu, S., Jennings, C., Sakaguchi, K., Kang, X., Southwood, S., Robbins, P. F., Sette, A., Appella, E., & Rosenberg, S. A. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.8.3961 · Cited by 540
Overwijk, W. W., Tsung, A., Irvine, K. R., Parkhurst, M. R., Goletz, T. J., Tsung, K., Carroll, M. W., Liu, C., Moss, B., Rosenberg, S. A., et al. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.2.277 · Cited by 493
Self-citationTumor immunogenicity determines the effect of B7 costimulation on T cell-mediated tumor immunity.
Chen, L., McGowan, P., Ashe, S., Johnston, J., Li, Y., Hellström, I., & Hellström, K. E. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.2.523 · Cited by 462
Two tyrosinase nonapeptides recognized on HLA‐A2 melanomas by autologous cytolytic T lymphocytes
Wölfel, T., Van Pel, A., Brichard, V., Schneider, J., Seliger, B., Zum Büschenfelde, K. M., & Boon, T. (1994) · European Journal of Immunology · doi:10.1002/eji.1830240340 · Cited by 411
Cooperative effects of INK4a and ras in melanoma susceptibility in vivo
Chin, L., Pomerantz, J., Polsky, D., Jacobson, M., Cohen, C., Cordon-Cardo, C., Horner, J. W., & DePinho, R. A. (1997) · Genes & Development · doi:10.1101/gad.11.21.2822 · Cited by 402
Identification of Tyrosinase-related Protein 2 as a Tumor Rejection Antigen for the B16 Melanoma
Bloom, M. B., Perry-Lalley, D., Robbins, P. F., Li, Y., El-Gamil, M., Rosenberg, S. A., & Yang, J. C. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.3.453 · Cited by 401
Cancer vaccines based on the identification of genes encoding cancer regression antigens
Rosenberg, S. A. (1997) · Immunology Today · doi:10.1016/s0167-5699(97)84664-6 · Cited by 386
Overwijk, W. W., Lee, D. S., Surman, D. R., Irvine, K. R., Touloukian, C. E., Chan, C.-C., Carroll, M. W., Moss, B., Rosenberg, S. A., & Restifo, N. P. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.2982 · Cited by 381
Self-citationHigh Avidity CTLs for Two Self-Antigens Demonstrate Superior In Vitro and In Vivo Antitumor Efficacy
Zeh, H. J., Perry-Lalley, D., Dudley, M. E., Rosenberg, S. A., & Yang, J. C. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.2.989 · Cited by 376
The selection and characterization of an invasive variant of the B16 melanoma.
Hart, I. R. (1979) · PubMed · Cited by 371
Vitiligo in Patients with Melanoma: Normal Tissue Antigens Can Be Targets for Cancer Immunotherapy
Rosenberg, S. A., & White, D. E. (1996) · Journal of Immunotherapy · doi:10.1097/00002371-199601000-00009 · Cited by 333
Preparation of Cell Cultures and Vaccinia Virus Stocks
Earl, P. L., Cooper, N., Wyatt, L. S., Moss, B., & Carroll, M. W. (1998) · Current Protocols in Protein Science · doi:10.1002/0471140864.ps0512s13 · Cited by 282
Identification of TRP-2 as a Human Tumor Antigen Recognized by Cytotoxic T Lymphocytes
Wang, R.-F., Appella, E., Kawakami, Y., Kang, X., & Rosenberg, S. A. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.184.6.2207 · Cited by 272
Otsuka, T., Takayama, H., Sharp, R., Celli, G. B., LaRochelle, W. J., Bottaro, D. P., Ellmore, N., Vieira, W., Owens, J. W., Anver, M. R., et al. (1998) · PubMed · doi:10.5281/zenodo.894795 · Cited by 268
Melanoma-specific CD4+ T cells recognize nonmutated HLA-DR-restricted tyrosinase epitopes.
Topalian, S. L., Gonzales, M. I., Parkhurst, M., Li, Y. F., Southwood, S., Sette, A., Rosenberg, S. A., & Robbins, P. F. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.5.1965 · Cited by 257
Wang, R. F., Parkhurst, M. R., Kawakami, Y., Robbins, P. F., & Rosenberg, S. A. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.3.1131 · Cited by 255
Tumor immunity and autoimmunity induced by immunization with homologous DNA.
Weber, L. W., Bowne, W. B., Wolchok, J. D., Srinivasan, R., Qin, J., Moroi, Y., Clynes, R., Song, P., Lewis, J. J., & Houghton, A. N. (1998) · Journal of Clinical Investigation · doi:10.1172/jci4004 · Cited by 228
Heteroclitic Immunization Induces Tumor Immunity
Dyall, R., Bowne, W. B., Weber, L. W., LeMaoult, J., Szabo, P., Moroi, Y., Piskun, G., Lewis, J. J., Houghton, A. N., & Nikolić-Žugić, J. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.9.1553 · Cited by 200
Parkhurst, M. R., Fitzgerald, E., Southwood, S., Sette, A., Rosenberg, S. A., & Kawakami, Y. (1998) · PubMed · Cited by 192
Hara, I., Takechi, Y., & Houghton, A. N. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.5.1609 · Cited by 184
Tsai, V, Southwood, S., Sidney, J., Sakaguchi, K., Kawakami, Y., Appella, E., Sette, A., & Celis, E. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.4.1796 · Cited by 175
A reassessment of the role of B7-1 expression in tumor rejection.
Wu, T. C., Huang, A. Y., Jaffee, E. M., Levitsky, H. I., & Pardoll, D. M. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.5.1415 · Cited by 171
Naftzger, C., Takechi, Y., Kohda, H., Hara, I., Vijayasaradhi, S., & Houghton, A. N. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.25.14809 · Cited by 160
Irvine, K. R., Chamberlain, R. S., Shulman, E., Surman, D. R., Rosenberg, S. A., & Restifo, N. P. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.21.1595 · Cited by 155
Self-citationSelf-Tolerance to the Murine Homologue of a Tyrosinase-Derived Melanoma Antigen
Colella, T. A., Bullock, T. N. J., Russell, L. B., Mullins, D. W., Overwijk, W. W., Luckey, C. J., Pierce, R. A., Restifo, N. P., & Engelhard, V. H. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.7.1221 · Cited by 153
Self-citationT cell-mediated, IFN-gamma-facilitated rejection of murine B16 melanomas.
Böhm, W., Thoma, S. J., Leithäuser, F., Mӧller, P., Schirmbeck, R., & Reimann, J. (1998) · PubMed · Cited by 150
Robbins, P. F., El‐Gamil, M., Li, Y. F., Fitzgerald, E., Kawakami, Y., & Rosenberg, S. A. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.1.303 · Cited by 133
Kittlesen, D. J., Thompson, L. W., Gulden, P. H., Skipper, J., Colella, T. A., Shabanowitz, J., Hunt, D. F., Engelhard, V. H., & Slingluff, C. L. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.5.2099 · Cited by 132
Brichard, V. G., Herman, J., Pel, A. V., Wildmann, C., Gaugler, B., Wölfel, T., Boon, T., & Lethé, B. (1996) · European Journal of Immunology · doi:10.1002/eji.1830260135 · Cited by 131
Identification of a MHC Class II-Restricted Human gp100 Epitope Using DR4-IE Transgenic Mice
Touloukian, C. E., Leitner, W. W., Topalian, S. L., Li, Y. F., Robbins, P. F., Rosenberg, S. A., & Restifo, N. P. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.7.3535 · Cited by 129
Self-citationT Cell-Mediated, IFN-γ-Facilitated Rejection of Murine B16 Melanomas
Böhm, W., Thoma, S. J., Leithäuser, F., Mӧller, P., Schirmbeck, R., & Reimann, J. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.2.897 · Cited by 122
Bronte, V., Apolloni, E., Ronca, R., Zamboni, P., Overwijk, W. W., Surman, D. R., Restifo, N. P., & Zanovello, P. (2000) · PubMed · Cited by 116
Self-citationKawakami, Y., Robbins, P. F., Wang, X., Tupesis, J. P., Parkhurst, M. R., Kang, X., Sakaguchi, K., Appella, E., & Rosenberg, S. A. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.12.6985 · Cited by 115
Mechanism of tumor cell resistance to lysis by syngeneic lymphocytes.
Fidler, I. J., & Bucana, C. D. (1977) · PubMed · Cited by 105
Skipper, J., Kittlesen, D. J., Hendrickson, R. C., Deacon, D. H., Harthun, N. L., Wagner, S. N., Hunt, D. F., Engelhard, V. H., & Slingluff, C. L. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.11.5027 · Cited by 100
The tyrosinase gene family--interactions of melanogenic proteins to regulate melanogenesis.
WINDER, A. F., Kobayashi, T., Tsukamoto, K., et al. (1994) · PubMed · Cited by 90
Kameyama, K., Sakai, C., Kuge, S., Nishiyama, S., TOMITA, Y., Ito, S., Wakamatsu, K., & Hearing, V. J. (1995) · Pigment Cell Research · doi:10.1111/j.1600-0749.1995.tb00648.x · Cited by 87
Overwijk, W. W., Surman, D. R., Tsung, K., et al. (1997) · Methods · doi:10.1006/meth.1997.0461 · Cited by 49
Self-citationEcotropic C-type retrovirus of B16 melanoma and malignant transformation of normal melanocytes
Li, M., Fan, X., Müller, J., Hearing, V. J., & Gorelik, E. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980504)76:3<430::aid-ijc23>3.0.co;2-d · Cited by 24
Cited by
Rogers, C., Erkes, D. A., Nardone, A., Aplin, A. E., Fernandes-Alnemri, T., & Alnemri, E. S. (2019) · Nature Communications · doi:10.1038/s41467-019-09397-2 · Cited by 826
Exploiting the Mutanome for Tumor Vaccination
Castle, J. C., Kreiter, S., Diekmann, J., Löwer, M., van de Roemer, N., de Graaf, J., Selmi, A., Diken, M., Boegel, S., Paret, C., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3722 · Cited by 810
Zander, R., Schauder, D., Xin, G., Nguyen, C., Wu, X., Zajac, A., & Cui, W. (2019) · Immunity · doi:10.1016/j.immuni.2019.10.009 · Cited by 648
Harrell, M. I., Iritani, B. M., & Ruddell, A. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.060761 · Cited by 388
Xu, F., Liu, J., Liu, D., Liu, B., Wang, M., Hu, Z., Du, X., Tang, L., & He, F. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2690 · Cited by 373
Metadata
- Authors
- Overwijk, W. W., & Restifo, N. P.
- Venue
- Current Protocols in Immunology
- Publisher
- Wiley
- Published
- 2000-10
- Volume
- 39
- Issue
- 1
- Pages
- Unit 20.1-Unit 20.1
- ISSN
- 1934-3671 (ISSN-L)
- 1934-368X
- OpenAlex
- W2129585732
- Cited by
- 434
- References
- 47
- FWCI
- 0.00
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.